首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1516093

心臟人工智慧監測和診斷市場，按產品（硬體、軟體解決方案、服務）、類型（心臟診斷、監測）、應用（心律不整、中風、缺血性心臟病、狹窄）、最終用途和預測，2024 - 2032

Cardiac AI Monitoring and Diagnostics Market, By Product (Hardware, Software Solutions, Services), Type (Cardiac Diagnostics, Monitoring), Application (Cardiac Arrhythmias, Stroke, Ischemic Heart Disease, Stenosis), End-use & Forecast, 2024 - 2032

出版日期: 2024年04月04日 | 出版商:

Global Market Insights Inc. | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在心血管疾病（CVD）盛行率不斷上升以及人口老化的推動下，心臟人工智慧監測和診斷市場預計在 2024 年至 2032 年期間複合年成長率將超過 26.9%。根據世界衛生組織的數據，心血管疾病 (CVD) 是死亡的主要原因，全球每年估計有 1,790 萬人死亡。

隨著心血管疾病成為發病和死亡的主要原因，需要有效的診斷工具來進行早期檢測和管理。人工智慧比傳統診斷方法有了顯著改進，可以對複雜的心臟資料進行準確、即時的分析，同時實現早期、準確的診斷。人工智慧與穿戴式裝置和遠端監測技術的整合還可以實現心臟健康的持續監測，這對於及時干預和個人化患者護理非常重要。

對衛生技術的重大投資和政府支持政策將鼓勵人工智慧在醫學研究中的採用。在心臟監測中使用人工智慧驅動的解決方案依賴巨量資料的不斷成長和機器學習演算法的進步，以提高系統的預測準確性和效率。科技公司和醫療保健提供者之間合作開發和部署新的人工智慧解決方案也正在推動市場成長。

心臟人工智慧監測和診斷產業分為產品、類型、應用、最終用途和地區。

根據產品，軟體解決方案領域的市場規模預計到 2032 年將創下強勁的複合年成長率，因為它能夠提供先進的演算法和機器學習模型，從而提高心臟診斷的準確性、有效性和範圍。該軟體解決方案支援即時資料分析、遠端監控和預測分析，同時讓醫療保健提供者全面了解患者的心臟健康狀況。易於使用的介面以及與醫療設備和電子健康記錄 (EHR) 系統的互通性可簡化臨床工作流程並改善患者治療結果，這將促進該細分市場的成長。

由於需要持續即時追蹤心臟健康狀況，預計心臟監測類型領域的心臟人工智慧監測和診斷市場在 2024 年至 2032 年間將大幅複合年成長率。人工智慧驅動的心臟監測設備，例如智慧穿戴設備和植入式感測器，可以準確、快速地了解心律、血壓和其他重要參數。將人工智慧融入心臟監測有助於對患者進行遠端監測，同時減少頻繁去醫院的需要，並改善慢性心臟衰竭的管理。

亞太地區心臟人工智慧監測和診斷產業將在2024年至2032年間持續成長。中國、印度和日本數位健康技術的快速採用和醫療保健的改善正在促進人工智慧與心臟病學的整合。政府在醫療保健創新方面的舉措和大量投資將進一步支持該地區由人工智慧驅動的心臟監測和診斷工具的開發。

產業生態系統分析
產業影響力
- 成長動力
  - 心血管疾病盛行率上升
  - 遠端監控解決方案的需求不斷成長
  - 技術進步
  - 日益關注精準醫療
- 產業陷阱與挑戰
  - 實施成本高
  - 互通性和整合有限
成長潛力分析
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
硬體
軟體解決方案
服務

第 6 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
心臟診斷
- 影像學
- 基於心電圖
- 其他診斷技術
心臟監測

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
心律不整
中風
缺血性心臟病
狹窄
其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
專科診所
診斷中心
研究和學術機構
其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

CardiAI
Cleerly, Inc.
DiA Imaging Analysis
HeartVista Inc.
IDOVEN
Koninklijke Philips N.V.
RSIP Vision
Tempus
Ultrasight
Ultromics Limited
Viz.ai, Inc.

簡介目錄

Product Code: 8858

Cardiac AI monitoring and diagnostics market is estimated to record over 26.9% CAGR during 2024-2032, driven by the increasing prevalence of cardiovascular diseases (CVDs), coupled with the aging population. As per WHO, cardiovascular diseases (CVDs) are the leading cause of mortality, with an estimated 17.9 million deaths per year worldwide.

With CVDs emerging as the major cause of morbidity and mortality, effective diagnostic tools are needed for early detection and management. AI offers significant improvements over traditional diagnostic methods for providing accurate, real-time analysis of complex cardiac data while allowing early and accurate diagnosis. The integration of AI with wearable devices and remote monitoring techniques is also enabling continuous monitoring of heart health, which is important for timely interventions and personalized patient care.

Major investments in health technology and supportive government policies will encourage the adoption of AI in medical research. The use of AI-driven solutions in cardiac monitoring relies on the growing availability of big data and advancements in ML algorithms to increase the predictive accuracy and efficiency of the systems. Partnerships between tech companies and healthcare providers to develop and deploy new AI solutions are also driving the market growth.

The cardiac AI monitoring and diagnostics industry is segmented into product, type, application, end-use and region.

Based on product, the market size from the software solutions segment is slated to record strong CAGR through 2032 due to its ability to provide advanced algorithms and ML models that increase the accuracy, efficacy, and scope of cardiac diagnosis. This software solution enables real-time data analytics, remote monitoring, and predictive analytics while giving healthcare providers a holistic view of the patient's cardiac health. Easy-to-use interfaces and interoperability with medical devices and electronic health record (EHR) systems to streamline clinical workflow and improve patient outcomes will add to the segment growth.

Cardiac AI monitoring and diagnostics market from the cardiac monitoring type segment is projected to observe substantial CAGR between 2024 and 2032, owing to the need for continuous and real-time tracking of heart health. AI-powered heart monitoring devices, such as smart wearables and implantable sensors, provide accurate and rapid insights into heart rhythms, blood pressure and other vital parameters. The integration of AI into cardiac monitoring facilitates the remote monitoring of patients while reducing the need for frequent hospital visits as well as improving the management of chronic heart failure.

Asia Pacific cardiac AI monitoring and diagnostics industry will witness sustained growth rate between 2024 and 2032. This is attributed to the increasing burden of cardiovascular diseases, driven by lifestyle changes, urbanization, and aging population. The rapid adoption of digital health technologies and improvements in healthcare in China, India and Japan are facilitating the integration of AI into cardiology. Government initiatives and large investments in healthcare innovation will further support the development and AI-powered cardiac monitoring and diagnostic tools in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of cardiovascular diseases
  - 3.2.1.2 Growing demand for remote monitoring solutions
  - 3.2.1.3 Technological advancements
  - 3.2.1.4 Increasing focus on precision medicine
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High implementation costs
  - 3.2.2.2 Limited interoperability and integration
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Hardware
5.3 Software solutions
5.4 Services

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Cardiac diagnostics
- 6.2.1 Imaging
- 6.2.2 ECG-based
- 6.2.3 Other diagnostic techniques
6.3 Cardiac monitoring

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Cardiac arrhythmias
7.3 Stroke
7.4 Ischemic heart disease
7.5 Stenosis
7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Specialty clinics
8.4 Diagnostic centers
8.5 Research and academic institutes
8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa